InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-18.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Elsbree David B, Director. Officer active across 1 company, notably T2 Biosystems, Inc.. Cumulatively, 7 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €120. History available since 13 September 2024. The latest transaction was filed on 13 September 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
55 shares@ US$2.42100.0% of flowCommon StockSEC:0000950170-24-107349:0
2,300 sharesCommon StockSEC:0000950170-23-052936:0
73,224 sharesCommon StockSEC:0000899243-22-024422:0
32,258 sharesCommon StockSEC:0000899243-22-000454
32,258 sharesCommon StockSEC:0000899243-22-000454:0
45,454 sharesCommon StockSEC:0000899243-21-026528
45,454 sharesCommon StockSEC:0000899243-21-026528:0
7 of 7 declarations
About Elsbree David B
David B. Elsbree is a Board Member at T2 Biosystems, Inc. He contributes to the governance of the company by bringing his expertise in the health technology sector. David plays a key role in evaluating growth strategies and overseeing development initiatives. His industry experience is a valuable asset to T2 Biosystems' management team.
